By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Stratos Genomics today said that it has raised $2.1 million in a private financing from existing investors in the firm.

The privately-held Seattle-based firm is developing an ultra-low-cost nucleic acid sequencing technology for whole-genome analysis and molecular diagnostic applications. The firm, which is a spinoff of Stratos Group, has developed a single-molecule sequencing method called "sequencing by expansion."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.